Physician profile
Michael Owens
NPI 1568768455
$798.07
in general payments reported to CMS, 2019-2025
12 companies · $22.30 in 2025
The $22.30 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $49.61 · 2021: $102 · 2022: $226 · 2023: $39.01 · 2024: $28.89 · 2025: $22.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $281.11 | 2019-2025 | Shingrix, Bexsero, Pediarix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.25 | 2019-2023 | Jardiance |
| Pfizer INC. | $91.59 | 2019-2021 | |
| Novo Nordisk INC | $55.06 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $52.28 | 2019 | |
| Merck Sharp & Dohme LLC | $38.25 | 2019-2020 | |
| Sanofi Pasteur INC. | $21.37 | 2022 | |
| Seqirus USA INC | $19.67 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.49 | 2019 | |
| Esperion Therapeutics, INC. | $15.65 | 2021 | |
| Coopersurgical, INC. | $14.03 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.